These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20832359)

  • 1. Assessment of symptom control in patients with cancer in Northwestern Turkey.
    Kurt S; Unsar S
    Eur J Oncol Nurs; 2011 Apr; 15(2):137-44. PubMed ID: 20832359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate versus delayed self-reporting of symptoms and side effects during chemotherapy: does timing matter?
    Coolbrandt A; Van den Heede K; Vanhove E; De Bom A; Milisen K; Wildiers H
    Eur J Oncol Nurs; 2011 Apr; 15(2):130-6. PubMed ID: 20685164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on symptom control of structured information given to patients receiving chemotherapy.
    Mollaoğlu M; Erdoğan G
    Eur J Oncol Nurs; 2014 Feb; 18(1):78-84. PubMed ID: 24095215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-pharmacological interventions used by cancer patients during chemotherapy in Turkey.
    Can G; Erol O; Aydiner A; Topuz E
    Eur J Oncol Nurs; 2011 Apr; 15(2):178-84. PubMed ID: 20863758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatinum ototoxicity in children, long-term follow up.
    Al-Khatib T; Cohen N; Carret AS; Daniel S
    Int J Pediatr Otorhinolaryngol; 2010 Aug; 74(8):913-9. PubMed ID: 20846503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The experience of fatigue in Turkish patients receiving chemotherapy.
    Yurtsever S
    Oncol Nurs Forum; 2007 May; 34(3):721-8. PubMed ID: 17573331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study.
    Nieboer P; Buijs C; Rodenhuis S; Seynaeve C; Beex LV; van der Wall E; Richel DJ; Nooij MA; Voest EE; Hupperets P; Mulder NH; van der Graaf WT; TenVergert EM; van Tinteren H; de Vries EG
    J Clin Oncol; 2005 Nov; 23(33):8296-304. PubMed ID: 16219926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute infusion reactions to chemotherapeutic drugs: a single institute experience.
    Muallaoglu S; Disel U; Mertsoylu H; Besen A; Karadeniz C; Taner Sumbul A; Abali H; Ozyilkan O
    J BUON; 2013; 18(1):261-7. PubMed ID: 23613414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use and perceived efficacy of self-care activities in patients receiving chemotherapy.
    Nail LM; Jones LS; Greene D; Schipper DL; Jensen R
    Oncol Nurs Forum; 1991 Jul; 18(5):883-7. PubMed ID: 1891417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence and course of fatigue in breast cancer: the kind of chemotherapy plays a role].
    de Jong N; Candel M; Schouten H; Abu-Saad HH; Courtens A
    Pflege Z; 2005 Feb; 58(2):100-3. PubMed ID: 15754508
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictors of symptom experience in Korean patients with cancer undergoing chemotherapy.
    Kim HS; Oh EG; Lee H; Kim SH; Kim HK
    Eur J Oncol Nurs; 2015 Dec; 19(6):644-53. PubMed ID: 25958234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WISECARE+: Results of a European study of a nursing intervention for the management of chemotherapy-related symptoms.
    Kearney N; Miller M; Maguire R; Dolan S; MacDonald R; McLeod J; Maher L; Sinclair L; Norrie J; Wengström Y
    Eur J Oncol Nurs; 2008 Dec; 12(5):443-8. PubMed ID: 18842457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer.
    Pourgholami MH; Szwajcer M; Chin M; Liauw W; Seef J; Galettis P; Morris DL; Links M
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):597-605. PubMed ID: 19904538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom prevalence and longitudinal follow-up in cancer outpatients receiving chemotherapy.
    Yamagishi A; Morita T; Miyashita M; Kimura F
    J Pain Symptom Manage; 2009 May; 37(5):823-30. PubMed ID: 18804946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the mental status of rejected asylum seekers in two Danish asylum centers.
    Schwarz-Nielsen KH; Elklitt A
    Torture; 2009; 19(1):51-9. PubMed ID: 19491487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of nursing education as an intervention to decrease fatigue in Turkish patients receiving chemotherapy.
    Yesilbalkan OU; Karadakovan A; Göker E
    Oncol Nurs Forum; 2009 Jul; 36(4):E215-22. PubMed ID: 19581225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer.
    Brown DJ; McMillan DC; Milroy R
    Cancer; 2005 Jan; 103(2):377-82. PubMed ID: 15558809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Likelihood of a subsequent chemotherapy-induced nausea and vomiting (CINV) event in patients receiving low, moderately or highly emetogenic chemotherapy (LEC/MEC/HEC).
    Schwartzberg L; Szabo S; Gilmore J; Haislip S; Jackson J; Jain G; Balu S; Buchner D
    Curr Med Res Opin; 2011 Apr; 27(4):837-45. PubMed ID: 21309647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of asthma control in tertiary level in Turkey: a cross-sectional multicenter survey.
    Turktas H; Mungan D; Uysal MA; Oguzulgen K;
    J Asthma; 2010 Jun; 47(5):557-62. PubMed ID: 20560829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer.
    Papandreou CN; Daliani DD; Nix D; Yang H; Madden T; Wang X; Pien CS; Millikan RE; Tu SM; Pagliaro L; Kim J; Adams J; Elliott P; Esseltine D; Petrusich A; Dieringer P; Perez C; Logothetis CJ
    J Clin Oncol; 2004 Jun; 22(11):2108-21. PubMed ID: 15169797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.